{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:46:40Z","timestamp":1792036000802,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rcsop.2026.100819","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:47:44Z","timestamp":1782456464000},"page":"100819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SiMON-PRO-Hematology\u00ae: Digital techology for pharmacotherapeutic and patient reported outcomes monitoring in patients with hematologic malignancies"],"prefix":"10.1016","volume":"23","author":[{"given":"Alejandro Mart\u00ednez","family":"Pradeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Fern\u00e1ndez","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Jimeno","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Sanclaudio","family":"Luhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor Noriega","family":"Concepci\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Margusino-Frami\u00f1\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2026.100819_bb0005","author":"Organizaci\u00f3n: Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica (SEOM)"},{"issue":"11","key":"10.1016\/j.rcsop.2026.100819_bb0010","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2022.07.1941","article-title":"ESMO expert consensus statements on cancer survivorship: promoting high-quality survivorship care and research in Europe","volume":"33","author":"Vaz-Luis","year":"2022","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"14","key":"10.1016\/j.rcsop.2026.100819_bb0015","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1200\/JCO.2010.32.8427","article-title":"Long-term complications of Lymphoma and its treatment","volume":"29","author":"Ng","year":"2011","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.rcsop.2026.100819_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15245764","article-title":"Guidelines for the use and reporting of patient-reported outcomes in multiple myeloma clinical trials","volume":"15","author":"Laane","year":"2023","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100819_bb0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/17474086.2019.1613886","article-title":"Quality of life in multiple myeloma: considerations and recommendations","volume":"12","author":"Seitzler","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.rcsop.2026.100819_bb0030","first-page":"173","article-title":"Health-related quality of life in chronic myeloid leukaemia patients receiving long-term therapy with different tyrosine kinase inhibitors in Kurdistan region","volume":"354","author":"Ali","year":"2024","journal-title":"Georgian Med News"},{"issue":"9","key":"10.1016\/j.rcsop.2026.100819_bb0035","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.annonc.2022.04.007","article-title":"The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO clinical practice guideline","volume":"33","author":"Di Maio","year":"2022","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.rcsop.2026.100819_bb0040","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and reliability of the US National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol"},{"issue":"24","key":"10.1016\/j.rcsop.2026.100819_bb0045","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/jama.2022.9265","article-title":"Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial","volume":"327","author":"Basch","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.rcsop.2026.100819_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/PROM.S156291","article-title":"PROMs data: can it be used to make decisions for individual patients? A narrative review","volume":"10","author":"Field","year":"2019","journal-title":"Patient Relat Outcome Meas"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100819_bb0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/papr.12711","article-title":"PROMs for pain in adult cancer patients: a systematic review of measurement properties","volume":"19","author":"Abahussin","year":"2019","journal-title":"Pain Pract"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100819_bb0060","doi-asserted-by":"crossref","first-page":"E273","DOI":"10.1097\/NCC.0000000000000738","article-title":"\u201cI am sure that they use my PROM data for something important.\u201d A qualitative study about patients\u2019 experiences from a hematologic outpatient clinic","volume":"43","author":"Thestrup Hansen","year":"2020","journal-title":"Cancer Nurs"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100819_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s41687-020-00256-z","article-title":"User experiences on implementation of patient reported outcome measures (PROMs) in a haematological outpatient clinic","volume":"4","author":"Thestrup Hansen","year":"2020","journal-title":"J Patient-Rep Outcomes"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100819_bb0070","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s11136-021-03003-z","article-title":"Perceived benefits and limitations of using patient-reported outcome measures in clinical practice with individual patients: a systematic review of qualitative studies","volume":"31","author":"Campbell","year":"2022","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100819_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ejh.13774","article-title":"Important questions for the malignant hematologist to consider when designing or evaluating a study with patient-reported outcome measures (PROMs)","volume":"109","author":"Balitsky","year":"2022","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100819_bb0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.therap.2022.01.007","article-title":"Place des mesures rapport\u00e9es par les patients (PROMS\/PREMS) dans l\u2019\u00e9valuation et la valorisation des technologies de sant\u00e9 en France","volume":"77","author":"Roussel","year":"2022","journal-title":"Therapies"},{"issue":"16_suppl","key":"10.1016\/j.rcsop.2026.100819_bb0085","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1200\/JCO.2023.41.16_suppl.12011","article-title":"Web-based patient-reported outcome measures (PROMs) in elderly cancer patients: a French multicentric prospective feasibility trial (the FASTOCH study)","volume":"41","author":"Cancel","year":"2023","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100819_bb0090","doi-asserted-by":"crossref","first-page":"T69","DOI":"10.1016\/j.farma.2022.12.010","article-title":"[translated article] adherence and quality of life in patients with chronic lymphocytic leukemia treated with oral antineoplastic drugs","volume":"47","author":"Ochagav\u00eda Sufrategui","year":"2023","journal-title":"Farm Hosp"},{"issue":"11","key":"10.1016\/j.rcsop.2026.100819_bb0095","first-page":"3063","volume":"30","author":"Roberts","year":"2021","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehab"},{"key":"10.1016\/j.rcsop.2026.100819_bb0100","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1097\/01.HS9.0000852272.02314.8e","article-title":"PB2362: best practices on empowering and involving patients living with hematological malignancies on the development of novel patient-reported outcome measures","volume":"6","author":"Vrontaras","year":"2022","journal-title":"HemaSphere"},{"issue":"S3","key":"10.1016\/j.rcsop.2026.100819_bb0105","doi-asserted-by":"crossref","DOI":"10.1097\/01.HS9.0000973628.33317.72","article-title":"P1689: real-world evidence of using telemedicine to capture electronic prom improves quality of life assessment, healthcare resources management and overall survival in patients with lymphoma","volume":"7","author":"Ramos","year":"2023","journal-title":"HemaSphere"},{"key":"10.1016\/j.rcsop.2026.100819_bb0110","first-page":"231","article-title":"TRANSFoRm eHealth solution for quality of life monitoring","volume":"2016","author":"Saganowski","year":"2016","journal-title":"AMIA Jt Summits Transl Sci Proc AMIA Jt Summits Transl Sci"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100819_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266804","article-title":"Collection of cancer patient reported outcome measures (PROMS) to link with primary and secondary electronic care records to understand and improve long term cancer outcomes: a protocol paper","volume":"17","author":"Stamp","year":"2022","journal-title":"PloS One"},{"issue":"n01","key":"10.1016\/j.rcsop.2026.100819_bb0120","first-page":"68","article-title":"Intelligent MONitoring system for antiviral pharmacotherapy in patients with chronic hepatitis C (SiMON-VC)","volume":"41","author":"Margusino-Frami\u00f1\u00e1n","year":"2017","journal-title":"Farm Hosp Organo Expres Cient Soc Espanola Farm Hosp"},{"key":"10.1016\/j.rcsop.2026.100819_bb0125","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) v5.0","author":"U.S. Department of Health and Human Services","year":"2017"},{"key":"10.1016\/j.rcsop.2026.100819_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.826040","article-title":"Physicians\u2019 perceptions of clinical utility of a digital health tool for electronic patient-reported outcome monitoring in real-life hematology practice. Evidence from the GIMEMA-ALLIANCE platform","volume":"12","author":"Efficace","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100819_bb0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12955-020-01480-3","article-title":"Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy \u2013 a feasibility study","volume":"18","author":"Taarnh\u00f8j","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.rcsop.2026.100819_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2021.730722","article-title":"Fostering palliative care through digital intervention: a platform for adult patients with hematologic malignancies","volume":"3","author":"Koumakis","year":"2021","journal-title":"Front Digital Health"},{"issue":"10","key":"10.1016\/j.rcsop.2026.100819_bb0145","first-page":"4589","article-title":"Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives","volume":"28","author":"Aapro","year":"2020","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"10.1016\/j.rcsop.2026.100819_bb0150","doi-asserted-by":"crossref","DOI":"10.2196\/57342","article-title":"Usability and user experience testing of a co-designed electronic patient-reported outcomes app (\u201cMyPal for adults\u201d) for palliative cancer care: mixed methods study","volume":"12","author":"Bonotis","year":"2025","journal-title":"JMIR Hum Factors"},{"key":"10.1016\/j.rcsop.2026.100819_bb0155","article-title":"eSyM: an electronic health record\u2013integrated patient-reported outcomes\u2013based cancer symptom management program used by six diverse health systems","volume":"6","author":"Hassett","year":"2022","journal-title":"JCO Clin Cancer Inform"},{"issue":"22","key":"10.1016\/j.rcsop.2026.100819_bb0160","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1002\/cncr.32172","article-title":"Implementing electronic health record\u2013integrated screening of patient-reported symptoms and supportive care needs in a comprehensive cancer center","volume":"125","author":"Garcia","year":"2019","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.rcsop.2026.100819_bb0165","doi-asserted-by":"crossref","first-page":"e1219","DOI":"10.1634\/theoncologist.2018-0830","article-title":"Acceptability of routine evaluations using patient-reported outcomes of common terminology criteria for adverse events and other patient-reported symptom outcome tools in cancer outpatients: Princess Margaret Cancer Centre experience","volume":"24","author":"Albaba","year":"2019","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100819_bb0170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2307\/249008","article-title":"Perceived usefulness, perceived ease of use, and user acceptance of information technology","volume":"13","author":"Davis","year":"1989","journal-title":"MIS Q"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100819_bb0175","doi-asserted-by":"crossref","DOI":"10.2196\/23473","article-title":"Application of the eHealth literacy model in digital health interventions: scoping review","volume":"23","author":"El Benny","year":"2021","journal-title":"J Med Internet Res"},{"issue":"suppl 1","key":"10.1016\/j.rcsop.2026.100819_bb0180","first-page":"S35","article-title":"Approaching artificial intelligence to hospital pharmacy","volume":"48","author":"Gonz\u00e1lez-P\u00e9rez","year":"2024","journal-title":"Farm Hosp Organo Expres Cient Soc Espanola Farm Hosp"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100819_bb0185","first-page":"T195","article-title":"Cybersecurity: a priority for pharmacy services in the age of artificial intelligence","volume":"48","author":"Hern\u00e1ndez Mar\u00edn","year":"2024","journal-title":"Farm Hosp Organo Expres Cient Soc Espanola Farm Hosp"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100819_bb0190","first-page":"T198","article-title":"Ethical aspects of AI in hospital pharmacy","volume":"49","author":"Mart\u00ednez Sesmero","year":"2025","journal-title":"Farm Hosp Organo Expres Cient Soc Esp Farm Hosp"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276626001174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276626001174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:08:52Z","timestamp":1792033732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276626001174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"alternative-id":["S2667276626001174"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2026.100819","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SiMON-PRO-Hematology\u00ae: Digital techology for pharmacotherapeutic and patient reported outcomes monitoring in patients with hematologic malignancies","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2026.100819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100819"}}